4Hansson L. Success in the treatment of hypertension: a status report. Hypertension, 1997,15(Suppl 2):S11-S15.
5Daae LN, Westlie L. A 5-year comparison of doxazosin and atenolol in patients with mild to moderate hypertension:effects on blood pressure, serum lipids, and coronary heart disease risk. Blood press,1998,7(1):39-45.
6Elliott WJ, Black HR. Treatment of hypertension in the elderly. Am J Geriaty Cardiol, 2002,11(1):11-20.
7Raij L, Hayakawa H, Coffee K. et al. Effect of doxazosin on endothelial dysfunction in hypercholesterolemic/antioxidentdeficientrats. Am J Hypertens, 1997,10:1257-1262.
二级参考文献7
1Zannad F,Matzinger A,Larche J.Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.Am J Hypertens,1996;9(7):633-643
2Elliott HL,Meredith PA.Trough:peak ratio:clinically useful or practically irrelevant? J Hypertens,1995;13(3):279-283
3Coca A,Calvo C,Sobrino J,et al.Once-daily fixed-combination irbesartan 300mg/hydrochlorothiazide 25mg and circadian blood pressure profile in patients with essential hypertension.Clin Ther,2003;25 (11):2849-2864
4White WB,Lund-Johansen P,Omvik P.Twenty-four-hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy.J Hypertens Suppl,1993:11 (4):75-80
5Kochar M,Guthrie R,Triscari J,et al.Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.Am J Hypertens,1999;12(8 Pt 1):797-805
6Raskin P,Guthrie R,Flack J,et al.The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.J Hum Hypertens,1999;13(10):683-687
7Myers MG.Suggested guidelines for determining the troughto-peak ratio of antihypertensive drugs.Am J Hypertens,1996;9(10 Pt 2):76S-82S
